| CAS ID: | 135326-11-3 |
| Molecular Formula: | C23H30GdN3O11 |
| Molecular Weight: | 681.8 g/mol |
| Monoisotopic Mass: | 682.112 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C23H33N3O11.Gd/c1-2-37-18-5-3-16(4-6-18)9-17(26(14-22(33)34)15-23(35)36)10-24(11-19(27)28)7-8-25(12-20(29)30)13-21(31)32;/h3-6,17H,2,7-15H2,1H3,(H,27,28)(H,29,30)(H,31,32)(H,33,34)(H,35,36);/q;+3/p-3/t17-;/m0./s1 | See All |
| InChI Key: | PCZHWPSNPWAQNF-LMOVPXPDSA-K | |
| Smiles: | [H+].[H+].CCOC1=CC=C(C=C1)CC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Gd+3] | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00908596 | Disease | Nephrogenic systemic fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | May 27, 2009 | Last Verified | July 23, 2015 |
| Sponsor | Bayer | ||
| PubChem: | 56841043 |
| ChEMBL: |